NCT04089930View on ClinicalTrials.gov

Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

September 1, 2023

Study Completion Date

October 1, 2023

Conditions
Lupus Erythematosus
Interventions
DIAGNOSTIC_TEST

Immunogenicity

anti-VZV IgG titer and cell-mediated immunity (VZV-stimulated T cell spots)

Trial Locations (1)

000

Department of Medicine, Tuen Mun Hospital, Hong Kong

All Listed Sponsors
collaborator

The University of Hong Kong

OTHER

lead

Tuen Mun Hospital

OTHER_GOV

NCT04089930 - Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients | Biotech Hunter | Biotech Hunter